Medication info
Telmisartan and Amlodipine Tablet 80/5mg

Telmisartan and Amlodipine Tablet 80/5mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
GL Pharma Co., Ltd.
Appearance
White or off-white rectangular tablet
Packaging
30 tablets (10 tablets/Alu-Alu x 3), 30 tablets/bottle
Approval status
Active

MFDS item code 201903387 · Approved 2019.05.24 · Insurance code 649702190

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not adequately controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or above, amlodipine clearance is reduced; therefore, start treatment at a lower dose and increase the dose gradually.
Child dose
○ Children: Use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
GL Pharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication helps effectively lower and control blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with amlodipine or telmisartan monotherapy.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not adequately controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or above, amlodipine clearance is reduced; therefore, start treatment at a lower dose and increase the dose gradually.

Child dose

○ Children: Use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. If pregnancy is confirmed, this medication should be discontinued immediately. It should not be administered to individuals with hypersensitivity to specific ingredients, or to women who are pregnant or breastfeeding, as well as patients with severe liver disease or obstructive biliary disorders, and those with severe hypotension. Caution is also needed for patients with unstable heart failure following acute myocardial infarction or certain heart valve diseases. Patients with liver disease may require dosage adjustment due to slowed metabolism of this medication. Patients with gastrointestinal disorders should use caution due to the risk of gastrointestinal bleeding. Patients with impaired kidney function should periodically monitor renal status through blood tests, as there is a risk of worsening kidney function. Elderly patients may be more sensitive to this medication, so treatment should start at a lower dose and be gradually increased. This medication lowers blood pressure and may cause symptoms of hypotension; if such symptoms occur, the patient should be placed in a lying position and intravenous fluids should be administered if necessary. There may be an increase in potassium levels in the blood, so caution is needed when taking potassium supplements or potassium-containing medications. This medication may cause drowsiness or dizziness, so care should be taken when driving or operating machinery. Interaction with other medications may occur; therefore, consult a physician or pharmacist if taking other medications. In case of overdose, severe hypotension, heart rhythm disturbances, dizziness, etc., may occur, requiring immediate medical assistance. Safety and efficacy in children have not been established, so its use is not recommended.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 108 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylaxis reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • sensory abnormalities
  • sensory loss
  • dysgeusia
  • tremors
  • extrapyramidal symptoms
  • hypertonia
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease
  • hepatocellular carcinoma
  • cerebral infarction
  • congestive heart failure
  • musculoskeletal pain
  • neck pain
  • nasopharyngitis
  • upper abdominal discomfort
  • upper abdominal pain
  • positional dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container that protects it from light, and it is recommended to keep it at a temperature between 1 to 30 degrees Celsius. This will help maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

White or off-white rectangular tablet

Package unit

30 tablets (10 tablets/Alu-Alu x 3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.